CP Links: H1N1 influenza A Web resources
A collection of links for the most current, comprehensive information on H1N1.
All of the media attention surroung the H1N1 influenza A virus has struck fear in many people, especially parents. Information is power: From the New England Journal of Medicine to Sesame Street, we've pulled the most current, comprehensive information on H1N1 for you, your patients, and their parents.
AAP's H1N1 page:
From the American Academy of Pediatrics.
http://www.aap.org/advocacy/releases/swineflu.htm
AMA's flu page:
From the American Medical Association.
http://amafluhelp.org/
Can you get swine flu from pork?
Questions and answers from the United States Department of Agriculture.
http://www.usda.gov/wps/portal/!ut/p/_s.7_0_A/7_0_1OB?contentidonly=true&contentid=2009/04/0131.xml
CDC's H1N1 page:
Updated daily by the Centers for Disease Control and Prevention.
http://www.cdc.gov/h1n1flu/
Elmo vs H1N1:
The cast of Sesame Street shares tips on how to avoid H1N1.
http://contemporarypediatrics.modernmedicine.com/contpeds/article/articleDetail.jsp?id=623762
Google Flu Trends:
See how your region is being affected by the flu, tracked in real time.
http://www.google.org/flutrends/us/
PHAC's H1N1 flu page:
From the Public Health Agency of Canada.
http://www.fightflu.ca/
Medline's H1N1 page:
From the National Library of Medicine and the National Institutes of Health.
http://www.nlm.nih.gov/medlineplus/h1n1fluswineflu.html
NEJM's H1N1 site:
From the New England Journal of Medicine.
http://h1n1.nejm.org/
NIAID'S H1N1 page:
From the National Institute of Allergy and Infectious Diseases, one of the National Institutes of Health.
http://www3.niaid.nih.gov/topics/flu/default.htm
CDC recommends nirsevimab be prioritized for highest-risk infants amid limited availability
October 26th 2023The Centers for Disease Control and Prevention is advising providers to prioritize 100 mg doses of nirsevimab, a monoclonal antibody FDA-approved to prevent respiratory syncytial virus (RSV), for infants at the highest risk of severe RSV disease.
Navigating a complex case of pediatric COVID-19 with immunomodulatory therapies
October 21st 2023Eculizumab and anakinra should be considered in critically ill patients with severe infections that require immunomodulating therapies for life-threatening dysregulation, according to a poster session at the 2023 American Academy of Pediatrics National Conference & Exhibition.
